Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
2seventy bio, Inc.

2seventy bio, Inc. (TSVT) Stock Overview

Explore 2seventy bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TSVT●NASDAQ
HealthcareBiotechnology
$5.00
$0.00(0.00%)
U.S. Market opens in 14h 30m

2seventy bio, Inc. (TSVT)

Meyka AI Score

Z

Key Financials

Market Cap266.1M
P/E Ratio-4.55
EPS (TTM)$-0.08
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.51

TSVT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of 2seventy bio, Inc. (NASDAQ: TSVT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, 2seventy bio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TSVT on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.51 for the NASDAQ listing.

Key metrics behind 2seventy bio, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.55 and a market capitalization of 266.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TSVT on the NASDAQ.

Price Performance (NASDAQ: TSVT)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.01%
6-Month Change
49.70%
Year-to-Date (YTD) Change
68.92%
1-Year Change
19.05%
3-Year Change
-55.32%
5-Year Change
-63.69%
All-Time (Max) Change
-63.69%

Contact Information

https://www.2seventybio.com
339 499 9300
60 Binney Street, Cambridge, MA, 02142

Company Facts

650 Employees
IPO DateNov 3, 2021
CountryUS

Frequently Asked Questions